I'm betting on it being Taiwan and really hoping they will be announcing the binding agreement.
From the Taiwan announcement late Jan:
"FCL has until 4 April 2020 to provide the FDA with ancillary Prizma product information (including packaging and labelling) to allow for collection of the permit license in respect of the granted FDA regulatory approval (“Permit License”).
In accordance with the existing non-exclusive Memorandum of Understanding (MOU) between the Company and FCL (collectively “the Parties”), the Parties will commence negotiations in good faith, in order to execute a binding agreement to detail specific matters surrounding the distribution and services level requirements (including but not limited to distribution partners, cloud services, call centre operations, end-customer solutions) for the Prizma within Taiwan (refer previous announcements including that dated 10 November 2017)."
Happy to be wrong if it's NMPA
- Forums
- ASX - By Stock
- GMV
- Ann: Trading Halt
Ann: Trading Halt, page-22
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online